4.315

2.61% 0.095

Evotec Se Adr (EVO)

Overview News Price History Why EVO Down? Discussions Forecast Stock Split Dividend History

Evotec Se Adr stock is traded at $4.315, with a volume of 24,805. It is up +2.61% in the last 24 hours and up +0.46% over the past month. Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Previous Close:

$4.22

Open:

$4.34

24h Volume:

24,805

Relative Volume:

0.21

Market Cap:

$1.53B

Revenue:

$842.96M

Net Income/Loss:

$-185.63M

P/E Ratio:

-8.205

EPS:

-0.5259

Net Cash Flow:

$-228.52M

1W Performance:

-2.91%

1M Performance:

+0.46%

6M Performance:

+25.51%

1Y Performance:

-42.50%

1-Day Range:

$4.29

$4.35

1-Week Range:

$4.21

$4.47

52-Week Range:

$2.85

$7.98

Evotec Se Adr Stock (EVO) Company Profile

Name

Evotec Se Adr

Sector

Healthcare (1188)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

Address

Employee

5,022

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

EVO's Discussions on Twitter

Compare EVO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EVO Evotec Se Adr	4.29	1.53B	842.96M	-185.63M	-228.52M	-0.5259
ZTS Zoetis Inc	168.59	75.15B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.62	47.71B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.96	47.70B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.27	18.75B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.26	13.96B	612.78M	-86.37M	-62.91M	-0.87

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-07-24	Downgrade	Jefferies	Buy → Hold
Aug-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jul-29-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-11-24	Downgrade	Deutsche Bank	Buy → Hold
Apr-12-24	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-16-23	Downgrade	BofA Securities	Buy → Neutral
Jun-08-23	Upgrade	Citigroup	Neutral → Buy
Apr-04-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Dec-09-22	Initiated	H.C. Wainwright	Buy
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Aug-10-22	Downgrade	Morgan Stanley	Overweight → Underweight
Mar-02-22	Resumed	Cowen	Outperform
Jan-07-22	Resumed	Citigroup	Neutral